Citation Impact
1 by Nobel laureates 3 from Science/Nature 75 standout
Citing Papers
Multiple myeloma
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Works of Ying‐Ming Jou being referenced
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
2022
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
2016
Author Peers
| Author | Oncology | Hematology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Ying‐Ming Jou | 379 | 308 | 289 | 21 | 557 | |
| Rodrigo del Río do Valle | 3 | 1 | 30 | 35 | 291 | |
| Sonya L. Britt | 37 | 1.1k | ||||
| Dmitry Litvinov | 28 | 5 | 280 | 40 | 803 | |
| Finn Bowring | 7 | 23 | 208 | |||
| Mervyn G. Hardinge | 20 | 5 | 89 | 29 | 868 |
All Works
Loading papers...